Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 1
1987 3
1992 3
1993 3
1994 2
1995 3
1996 4
1997 5
1998 3
1999 7
2000 9
2001 12
2002 23
2003 25
2004 25
2005 36
2006 33
2007 44
2008 48
2009 62
2010 77
2011 77
2012 95
2013 69
2014 109
2015 134
2016 152
2017 189
2018 192
2019 187
2020 229
2021 300
2022 340
2023 352
2024 385
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,923 results

Results by year

Filters applied: . Clear all
Page 1
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T; LACE Collaborative Group. Pignon JP, et al. Among authors: ding k. J Clin Oncol. 2008 Jul 20;26(21):3552-9. doi: 10.1200/JCO.2007.13.9030. Epub 2008 May 27. J Clin Oncol. 2008. PMID: 18506026
Response.
Ji Y, Bo C, Xue X, Weng E, Gao G, Dai B, Ding K, Xu C. Ji Y, et al. Among authors: ding k. J Pain Symptom Manage. 2017 Dec;54(6):e3. doi: 10.1016/j.jpainsymman.2017.09.003. Epub 2017 Sep 13. J Pain Symptom Manage. 2017. PMID: 28916292 Free article. No abstract available.
Intermittent androgen suppression for rising PSA level after radiotherapy.
Crook JM, O'Callaghan CJ, Duncan G, Dearnaley DP, Higano CS, Horwitz EM, Frymire E, Malone S, Chin J, Nabid A, Warde P, Corbett T, Angyalfi S, Goldenberg SL, Gospodarowicz MK, Saad F, Logue JP, Hall E, Schellhammer PF, Ding K, Klotz L. Crook JM, et al. Among authors: ding k. N Engl J Med. 2012 Sep 6;367(10):895-903. doi: 10.1056/NEJMoa1201546. N Engl J Med. 2012. PMID: 22931259 Free PMC article. Clinical Trial.
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y; RELARC Study Group. Xu L, et al. Among authors: ding k. Lancet Oncol. 2021 Mar;22(3):391-401. doi: 10.1016/S1470-2045(20)30685-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587893 Clinical Trial.
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.
Hu H, Zhang J, Li Y, Wang X, Wang Z, Wang H, Kang L, Liu P, Lan P, Wu X, Zhen Y, Pei H, Huang Z, Zhang H, Chen W, Zeng Y, Lai J, Wei H, Huang X, Chen J, Chen J, Tao K, Xu Q, Peng X, Liang J, Cai G, Ding K, Ding Z, Hu M, Zhang W, Tang B, Hong C, Cao J, Huang Z, Cao W, Li F, Wang X, Wang C, Huang Y, Zhao Y, Cai Y, Ling J, Xie X, Wu Z, Shi L, Ling L, Liu H, Wang J, Huang M, Deng Y; OPTICAL study group. Hu H, et al. Among authors: ding k. J Clin Oncol. 2024 Sep 1;42(25):2978-2988. doi: 10.1200/JCO.23.01889. Epub 2024 Apr 2. J Clin Oncol. 2024. PMID: 38564700 Clinical Trial.
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial.
Lu J, Xing J, Zang L, Zhang C, Xu L, Zhang G, He Z, Sun Y, Feng Y, Du X, Hu S, Chi P, Huang Y, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Y, Zhang Z, Zheng M, Su X, Xiao Y; RELARC study group. Lu J, et al. Among authors: ding k. J Clin Oncol. 2024 Nov 20;42(33):3957-3966. doi: 10.1200/JCO.24.00393. Epub 2024 Aug 27. J Clin Oncol. 2024. PMID: 39190853 Clinical Trial.
Immunotherapy for EBV-Associated Nasopharyngeal Carcinoma.
Hong M, Tang K, Qian J, Deng H, Zeng M, Zheng S, Ding K, Du Y, Sun R. Hong M, et al. Among authors: ding k. Crit Rev Oncog. 2018;23(3-4):219-234. doi: 10.1615/CritRevOncog.2018027528. Crit Rev Oncog. 2018. PMID: 30311576 Review.
Reflections on Organic Chemistry in China.
Ding K. Ding K. Org Lett. 2020 Nov 6;22(21):8179-8180. doi: 10.1021/acs.orglett.0c03299. Epub 2020 Oct 12. Org Lett. 2020. PMID: 33044832 No abstract available.
Epilepsy after Traumatic Brain Injury.
Ding K, Gupta PK, Diaz-Arrastia R. Ding K, et al. In: Laskowitz D, Grant G, editors. Translational Research in Traumatic Brain Injury. Boca Raton (FL): CRC Press/Taylor and Francis Group; 2016. Chapter 14. In: Laskowitz D, Grant G, editors. Translational Research in Traumatic Brain Injury. Boca Raton (FL): CRC Press/Taylor and Francis Group; 2016. Chapter 14. PMID: 26583175 Free Books & Documents. Review.
2,923 results